early in the conversation it was mention the main setback or risk factor is the biggest marekt the US and FDA approval, which seem forever for those waiting. but the bigger risk in now trump, pro US manufacturing and those tariffs...but expect there will be exemtion to be had and bubs will be in that, but till that happens might be alot of ups and downs re Sp, Overall seem very undervalued iwth all the past history and loss making, concerns over management, but believe that has changed, with also china like to grow and grow(wonder aboutthe margins there?) US to grow, and likely other market to open up, and would wonder about the need for expanisin (and likely huge costs? ) to meet prodcution increases, did i seee mention now at 84% capicity, or was that just for one location reference.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)